Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT03485482 Completed - Clinical trials for Cardiovascular Diseases

Pharmacokinetic Drug-Drug Interaction Between Bisoprolol and Ivabradine in Healthy Volunteers

Start date: March 1, 2018
Phase: Phase 3
Study type: Interventional

The purpose of the study was to investigate the potential interaction between ivabradine and bisoprolol in healthy subjects.

NCT ID: NCT03485222 Completed - Clinical trials for Cardiovascular Diseases

Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).

EMPA-TROPISM
Start date: May 21, 2018
Phase: Phase 4
Study type: Interventional

Purpose: The overall hypothesis of the study is that the benefits attained in the EMPA-OUTCOME were, at least in part, mediated by a glucose-independent mechanism. Thus, to demonstrate the existence of the postulated non-glucose dependent effects, the researchers will investigate the safety and efficacy of empagliflozin versus placebo on top of guideline-directed medical therapy in heart failure patients with reduced ejection fraction without diabetes.

NCT ID: NCT03479697 Completed - Hypertension Clinical Trials

HIRREM for Stage 1 Primary Hypertension

HIRREM
Start date: August 8, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to determine that effects of an intervention called High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM), on Stage 1 Primary Hypertension (systolic BP 130-139, and/or diastolic BP 80-89).

NCT ID: NCT03479658 Completed - Adiposity Clinical Trials

Dose-effect of HIIT on Cardiovascular Health of Children

Start date: February 27, 2018
Phase: N/A
Study type: Interventional

An adequate physical activity level has important effects on cardiovascular health of children. However, the scientific literature suggests that few children meet the physical activity recommendations to obtain these cardiovascular benefits which may have immediate and long term consequences in public health. High intensity interval training (HIIT) has emerged as an effective strategy for improving physical and mental health in children. To note that HIIT can be completed in a shorter period of time and its results in physical health seem to be equivalent to those obtained in longer sessions of traditional aerobic training. However, there is no information about the dose of HIIT needed to obtain significant effects on cardiovascular health of children. The adoption of healthy dietary habits is also important in the prevention of obesity and cardiovascular diseases. School-based programs including physical activity and nutritional education have been recommended as important components of programs aiming to prevent obesity and cardiovascular diseases.

NCT ID: NCT03479177 Completed - Clinical trials for Cardiovascular Diseases

Home-Based High Intensity Interval Training Intervention for Low Active Adults

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effect of a home-based high intensity interval training intervention on exercise among low active adults (defined as engaging in exercise 90 minutes or less per week). Participants will be randomly assigned to a HIIT-based intervention or a wait-list control each lasting 12 weeks (participants in the wait-list control condition will have the option of receiving the HIIT intervention following the 12 weeks).

NCT ID: NCT03477331 Completed - Clinical trials for Cardiovascular Diseases

Antithrombotics' Therapeutic Optimization in Hospitalized Patients Using Physiologically- and Population-based Pharmacokinetic Modeling

OptimAT
Start date: January 14, 2018
Phase:
Study type: Observational

The main goal of the OptimAT study main goal is to validate a PBPK model for 3 direct oral anticoagulants (rivaroxaban, apixaban, dabigatran) and 3 P2Y12 inhibitors (clopidogrel, ticagrelor, prasugrel) in hospitalized patients.

NCT ID: NCT03472898 Completed - Clinical trials for Cardiovascular Diseases

Gated SPECT Abnormality With J Point Elevation

Start date: December 27, 2017
Phase:
Study type: Observational

The investigators present an interesting co-incidence of Gated wall abnormality in the inferolateral wall in normal sestamibi myocardial perfusion images with J wave in the inferior derivations of the ECG in a patient. The subsequent coronary angiography demonstrated 80% mid right coronary artery (RCA) stenosis, which was intervened with a drug-eluting stent. The investigators conclude that even though the myocardial perfusion is normal, the association of gated wall abnormality with J wave presentation within the same location should be further evaluated.

NCT ID: NCT03470701 Completed - Hypertension Clinical Trials

Improving Albuminuria Screening Compliance Using a Smartphone Urinalysis Kit

Start date: March 19, 2018
Phase: N/A
Study type: Interventional

This study will test the effectiveness of mailed, smartphone urinalysis kits to improve albuminuria screening compliance and detection of albuminuria.

NCT ID: NCT03470584 Completed - Stroke Clinical Trials

Vegetarian Diet and Chronic Degenerative Diseases

Start date: March 1, 2005
Phase:
Study type: Observational

To investigate the prospective association between a vegetarian diet and chronic degenerative diseases in two cohorts of Taiwanese Buddhists

NCT ID: NCT03468179 Completed - Obesity Clinical Trials

Oatmeal Effect on N-acyl-phosphatidylethanolamines

NAPE
Start date: October 7, 2018
Phase: N/A
Study type: Interventional

N-acyl-phosphatidylethanolamine (NAPEs) and their active metabolites, N-acyl-ethanolamides (NAEs) are lipid satiety factors that are normally biosynthesized in the intestinal tract in response to food intake. Reduced levels of NAPEs and NAEs have been found in obese individuals, and increasing plasma NAPE and NAEs levels may be beneficial to obese individuals trying to lose weight or to keep off weight gain after losing weight. We have found that oatmeal has large amounts of NAPEs, and based on previous mouse studies, we hypothesize that a single dose of dietary oatmeal is sufficient to double plasma NAE from baseline, possibly inducing satiety and increasing basal metabolic rate. To test this hypothesis, we will feed volunteers a single weight-based serving of oatmeal while monitoring its effects on serum glucose, NAPE and NAE levels as well as on subjective satiety.